|
|
Volumn 260, Issue 1, 2010, Pages 59-68
|
|
The European post-marketing observational sertindole study: An investigation of the safety of antipsychotic drug treatment
a
|
|
Author keywords
Antipsychotic; EPOS; Mortality; Safety; Sertindole
|
|
Indexed keywords
CLOZAPINE;
FLUPENTIXOL;
HALOPERIDOL;
HALOPERIDOL DECANOATE;
LEVOMEPROMAZINE;
NEUROLEPTIC AGENT;
OLANZAPINE;
RISPERIDONE;
SERTINDOLE;
IMIDAZOLE DERIVATIVE;
INDOLE DERIVATIVE;
ABDOMINAL PAIN;
ACCIDENTAL INJURY;
AGRANULOCYTOSIS;
AKATHISIA;
ALCOHOL INTOLERANCE;
ANGINA PECTORIS;
ANXIETY;
ARTICLE;
BONE DISEASE;
BRADYCARDIA;
BRAIN ISCHEMIA;
BRONCHITIS;
BRONCHOPNEUMONIA;
CHOLECYSTITIS;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL PRACTICE;
CLINICAL TRIAL;
CONGENITAL BLOOD VESSEL MALFORMATION;
CONTROLLED STUDY;
CONVULSION;
CYST;
CYSTITIS;
DEPRESSION;
DRUG FATALITY;
DRUG SAFETY;
DRUG SUBSTITUTION;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DUODENUM BLEEDING;
ECG ABNORMALITY;
EJACULATION;
EPISTAXIS;
EUROPE;
EXTRAPYRAMIDAL SYMPTOM;
FEMALE;
FEVER;
GAIT DISORDER;
GASTRITIS;
GASTROINTESTINAL DISEASE;
GLAUCOMA;
GRAND MAL EPILEPSY;
HEADACHE;
HEART ARRHYTHMIA;
HEART ATRIUM FIBRILLATION;
HEART INFARCTION;
HEART MUSCLE ISCHEMIA;
HEMATEMESIS;
HEMATURIA;
HUMAN;
HYPONATREMIA;
HYPOTENSION;
HYPOTHERMIA;
ILEUS;
INFECTION;
INSOMNIA;
INTESTINE PERFORATION;
IRON DEFICIENCY ANEMIA;
LEG EDEMA;
LIVER FUNCTION;
LUNG CARCINOMA;
LUNG DISEASE;
LUNG EMBOLISM;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
MUSCLE HYPERTONIA;
NAUSEA;
NUTRITIONAL DISORDER;
PAIN;
PATHOLOGIC FRACTURE;
PLEURA DISEASE;
PNEUMONIA;
POSTMARKETING SURVEILLANCE;
PRIORITY JOURNAL;
PSEUDOLYMPHOMA;
PSYCHOSIS;
QT PROLONGATION;
RECTUM HEMORRHAGE;
RESPIRATORY TRACT DISEASE;
RETINA DETACHMENT;
RHINITIS;
SCHIZOPHRENIA;
SEPSIS;
SHOCK;
SIDE EFFECT;
SKIN TUMOR;
SLEEP APNEA SYNDROME;
SUICIDE ATTEMPT;
SYNCOPE;
TENDON RUPTURE;
TENOSYNOVITIS;
THORAX PAIN;
THROMBOCYTOPENIA;
THYROID CARCINOMA;
TREATMENT DURATION;
TREMOR;
ULCER;
UNSPECIFIED SIDE EFFECT;
WEIGHT GAIN;
ADOLESCENT;
ADULT;
CHEMICALLY INDUCED DISORDER;
DRUG SURVEILLANCE PROGRAM;
ELECTROCARDIOGRAPHY;
FOLLOW UP;
HOSPITALIZATION;
LONG QT SYNDROME;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
PATIENT COMPLIANCE;
PSYCHOLOGICAL RATING SCALE;
SAFETY;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
ANTIPSYCHOTIC AGENTS;
ELECTROCARDIOGRAPHY;
EUROPE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMIDAZOLES;
INDOLES;
LONG QT SYNDROME;
MALE;
MIDDLE AGED;
PATIENT COMPLIANCE;
PRODUCT SURVEILLANCE, POSTMARKETING;
PSYCHIATRIC STATUS RATING SCALES;
SAFETY;
SCHIZOPHRENIA;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
YOUNG ADULT;
|
|
EID: 77950352932
PISSN: 09401334
EISSN: None
Source Type: Journal
DOI: 10.1007/s00406-009-0018-0 Document Type: Article |
|
Times cited : (29)
|
|
References (15)
|
